Studies developed on different carcinoma localizations such as breast cancer [10,11] have proved that MUC1 mucin can elicit a humoral immune response; furthermore, we have detected free and complexed anti-MUC1 antibodies in serum samples belonging to breast cancer patients [12]. Here, MUC1 is linked to breast carcinoma.